Welcome to our dedicated page for Everlert news (Ticker: EVLI), a resource for investors and traders seeking the latest updates and insights on Everlert stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Everlert's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Everlert's position in the market.
Everlert (OTC: EVLI) completed a strategic reverse-merger with Italian luxury apparel company Zanieri on December 30, 2025, making Zanieri the controlling shareholder.
Zanieri contributed its operating business into Everlert, exchanged preferred stock classes to acquire control, and integrated its management, manufacturing, and proprietary remote-tailoring platform into the public company. Zanieri reports over 70% revenue from white-label manufacturing and ~95% of 2025 gross sales from European operations.
The combined company plans U.S. expansion including a New York flagship and DTC e-commerce, has exited court custodianship, submitted disclosures to OTC Markets for review, and is engaging a PCAOB-registered auditor while evaluating a potential uplisting.
FAQ
What is the current stock price of Everlert (EVLI)?
